However, there is increasing evidence that genetic PI3K pathway activation in cancer might be a graded event, similar to observations of oncogenic K-Ras [18], with the presence of more than one mutant copy of PIK3CA and/or genetic activation of other PI3K pathway components seen in established tumours [4]. The gene discussed is PIK3CD; the disease is neoplasm.